wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38084363-DE7BEE34-0191-46FC-9413-0D92323E07AE
Q38084363-DE7BEE34-0191-46FC-9413-0D92323E07AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38084363-DE7BEE34-0191-46FC-9413-0D92323E07AE
SGLT2 inhibition: a novel prospective strategy in treatment of diabetes mellitus.
P2860
Q38084363-DE7BEE34-0191-46FC-9413-0D92323E07AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38084363-DE7BEE34-0191-46FC-9413-0D92323E07AE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7f9ca0c07505b7cae50b499fdd5842ca57b993f4
P2860
Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level.